Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 3:4:303.
doi: 10.3389/fonc.2014.00303. eCollection 2014.

National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned

Affiliations

National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned

Rosemary S L Wong et al. Front Oncol. .

Abstract

Purpose: To increase access of underserved/health disparities communities to National Cancer Institute (NCI) clinical trials, the Radiation Research Program piloted a unique model - the Cancer Disparities Research Partnership (CDRP) program. CDRP targeted community hospitals with a limited past NCI funding history and provided funding to establish the infrastructure for their clinical research program.

Methods: Initially, 5-year planning phase funding was awarded to six CDRP institutions through a cooperative agreement (U56). Five were subsequently eligible to compete for 5-year implementation phase (U54) funding and three received a second award. Additionally, the NCI Center to Reduce Cancer Health Disparities supported their U56 patient navigation programs.

Results: Community-based hospitals with little or no clinical trials experience required at least a year to develop the infrastructure and establish community outreach/education and patient navigation programs before accrual to clinical trials could begin. Once established, CDRP sites increased their yearly patient accrual mainly to NCI-sponsored cooperative group trials (~60%) and Principal Investigator/mentor-initiated trials (~30%). The total number of patients accrued on all types of trials was 2,371, while 5,147 patients received navigation services.

Conclusion: Despite a historical gap in participation in clinical cancer research, underserved communities are willing/eager to participate. Since a limited number of cooperative group trials address locally advanced diseases seen in health disparities populations; this shortcoming needs to be rectified. Sustainability for these programs remains a challenge. Addressing these gaps through research and public health mechanisms may have an important impact on their health, scientific progress, and efforts to increase diversity in NCI clinical trials.

Keywords: access to clinical trials; cancer disparities; clinical research; patient accrual; underserved populations.

PubMed Disclaimer

References

    1. Frank S. Govern PhD was the Primary Creator of this Innovative Model that Reversed the Traditional Flow of Funding.
    1. TELESYNERGY™. Available at: http://telesynergy.nih.gov/index.html
    1. NOVA Research Company. Available at: http://www.novaresearch.com
    1. Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, et al. Assessing cancer stage and screening disparities among Native American cancer patients. Public Health Rep (2009) 124:79–89. - PMC - PubMed
    1. Guadagnolo BA, Cina K, Koop D, Brunette D, Petereit DG. A pre-post survey analysis of satisfaction with health care and medical mistrust after patient navigation for American Indian cancer patients. J Health Care Poor Underserved (2009) 22:1331–43.10.1353/hpu.2011.0115 - DOI - PMC - PubMed

LinkOut - more resources